Filing Flows › Health Care › GE HealthCare Technologies (GEHC)
GE HealthCare Technologies (GEHC) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Oct 28, 2026 · GE HealthCare Technologies (GEHC) Q3 2026 earnings results →
Q3 2026 Revenue up 7% year over year to $5.5B · 11¢ of every $1 of revenue kept as net profit · operating margin 14.6%
GE HealthCare Technologies made $5.5B in Q3 2026 (+7% Y/Y): Product $3.6B, Service $1.9B. Operating margin 14.6%, net earnings $615M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 28, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $5.5B in Q3 2026, up 7% year over year and up 4% from the previous quarter. Product was the largest line at 65% of revenue. Product added $0.23B year over year (up 7%), 61% of the total change.
Gross margin was 40.3%, up 1.6 points from Q3 2025. Operating profit was $0.81B, a 14.6% margin (up 1.9 points year over year). Of the extra revenue versus Q3 2025, 41% reached operating profit, above the 13% margin then. Operating expenses grew 6% against revenue growth of 7%. Net earnings were $0.61B, up 38% year over year. The effective tax rate was 17.2%.
Operating cash flow was $0.91B (up 53% year over year), 146% of net earnings. Non-cash charges added back $0.16B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items added $0.09B. Capital expenditures of $0.11B left free cash flow of $0.79B.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Oct 28, 2026 | $5.5B | +7% | 14.6% | $615M | $907M |
| Q2 2026 | 10-Q | Jul 29, 2026 | $5.3B | +6% | 14.0% | $561M | $168M |
| Q1 2026 | 10-Q | Apr 29, 2026 | $5.1B | +7% | 10.0% | $389M | $290M |
| Q4 2025 | 10-K | Feb 4, 2026 | $5.7B | +7% | 14.5% | $589M | $1.1B |
| Q3 2025 | 10-Q | Oct 29, 2025 | $5.1B | +6% | 12.7% | $446M | $593M |
| Q2 2025 | 10-Q | Jul 30, 2025 | $5.0B | +4% | 13.1% | $486M | $94.0M |
| Q1 2025 | 10-Q | Apr 30, 2025 | $4.8B | +3% | 13.2% | $564M | $250M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About GE HealthCare Technologies
GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care. This is complemented by our broad service capabilities and dedication to quality and integrity with a strong operational culture, supported by our lean business system, Heartbeat.
In its own words, from its 10-K, filed Feb 4, 2026.
GE HealthCare Technologies against its X-Ray Apparatus & Tubes & Related Irradiation Apparatus peers
The largest companies of the same SEC industry, each at its latest quarter.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Q3 2026 | $5.5B | +7% | 14.6% |
| BFLY Butterfly Network | Q3 2026 | $32.6M | +52% | -41.7% |
Source: GE HealthCare Technologies 10-Q on SEC EDGAR · CIK 1932393 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Guidance and outlook
13F: who owns GEHC and who is buying
More on GEHC
- How GE HealthCare Technologies makes money: revenue by segment
- GE HealthCare Technologies next earnings date and what analysts expect
- GE HealthCare Technologies stock forecast, price target and fair value
- Who owns GE HealthCare Technologies stock: holders, funds and Congress trades
- GE HealthCare Technologies guidance and outlook
- Is GE HealthCare Technologies a takeover target? LBO and rumors
- GE HealthCare Technologies recalls, complaints and regulation
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- GE HealthCare Technologies guidance history: guided vs reported
- GE HealthCare Technologies gross margin by quarter
- GE HealthCare Technologies operating margin by quarter
- GE HealthCare Technologies net income by quarter
- GE HealthCare Technologies free cash flow by quarter
- GE HealthCare Technologies R&D spending by quarter
- GE HealthCare Technologies capital expenditures by quarter
- GE HealthCare Technologies Product revenue by quarter
- GE HealthCare Technologies Service revenue by quarter